Please login to the form below

Not currently logged in
Email:
Password:

China

This page shows the latest China news and features for those working in and with pharma, biotech and healthcare.

GSK sells eczema and psoriasis drug to Dermavant for £250m

GSK sells eczema and psoriasis drug to Dermavant for £250m

targets. The deal covers all markets except for China. Tapinarof, a therapeutic aryl hydrocarbon receptor modulating agent (TAMA), is being developed as a once-daily, topical treatment for the skin disorders

Latest news

More from news
Approximately 92 fully matching, plus 531 partially matching documents found.

Latest Intelligence

  • If you’re going global, go local and go early If you’re going global, go local and go early

    It was the initial planning work carried out in India and China that ultimately revealed the emerging trends and the behavioural insights that supported the global strategy; the same strategy that

  • Shaping healthcare Shaping healthcare

    One came from my time leading Bayer in China. What really matters is understanding how the people within the company tick and how they orientate themselves towards the right targets and ... Your time in China didn’t coincide with GSK’s

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Whether the EU shares that view remains to be seen. The challenge for UK businesses is that the life science environment is becoming more competitive globally, with developing markets like China,

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    Colistin is considered the last line of defence against multidrug-resistant organisms and using it as an animal feed supplement is unacceptable and is already banned in China and Europe. ... Yet colistin resistance is already here and spreading worldwide.

  • Deal Watch January 2018

    Royalty monetisation. 230. Jiangsu Hengrui Medicine/Arcutis. SHR0302, selective JAK inhibitor, for dermatology disorders (currently p2 for RA in China).

More from intelligence
Approximately 13 fully matching, plus 100 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 33 partially matching documents found.

Latest from PMHub

  • AMICULUM boosts global healthcare communications offering with a new specialist agency, Seques®

    About AMICULUM. AMICULUM ( www.amiculum.biz) is an independent global healthcare communications, consulting and learning business with a global team of over 220 healthcare communications professionals, based in New Zealand, China,

  • Pharma China Annual Forum 2017

    Pharma China Annual Forum 2017. We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China. ... 00. The patient is an important stakeholder in the treatment of chronic conditions in urban China.

  • 12 Challenges Big Pharma Faces in China

    12 Challenges Big Pharma Faces in China. Published in eyeforpharma 16 November by Rachel Howard. ... www.researchpartnership.com/news/2015/11/article-12-challenges-big-pharma-faces-in-china/.

  • Webinar: Understanding the patient journey in China

    Webinar: Understanding the patient journey in China. The Chinese healthcare market is experiencing a period of great change. ... Identify the opportunities and challenges associated with the healthcare reforms. Learn how to ensure that your market

  • Pharma CI Asia Conference & Exhibition 2017

    Pharma CI Asia Conference &Exhibition 2017. 13-14 July 2017, Singapore. Research Partnership is delighted to be attending the Pharma CI Asia Conference and Exhibition in Singapore 13-14 July. The event is regarded as the largest assembly of

More from PMHub
Approximately 13 fully matching, plus 68 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics